ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

August 25, 1978

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI

February 16, 1990